Additional Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    University of Alberta Hospital (University of Alberta)
    Edmonton AB. T6G 1Z1
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Dartmouth-Hitchcock Medical Center
    Lebanon NH. 03756
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Mayo Clinic, Rochester
    Rochester MN. 55905
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    University of Pennsylvania
    Philadelphia PA. 19104
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Vancouver General Hospital
    Vancouver BC. V5Z 1M9
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Dr. Syed Anees Medicine Professional Corporation
    Windsor ON. N8X 1T3
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Kelowna Respirology & Allergy Research
    Kelowna BC. V1Y 3H5
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Dr. Georges-L.-Dumont University Hospital Centre
    Moncton NB. E1C 2Z3
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    QEII Health Sciences Centre
    Halifax NS. B3H 3A7
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Charleston SC. 29425
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Baltimore MD. 21224
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Cleveland OH. 44195
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Philadelphia PA. 19140
    View Details

  • Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

    Clinical Physiology Laboratory
    Edmonton AB. T6G2R3
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Temple University
    Philadelphia PA. 19140
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Georgetown University Medical Center - Department of Rheumatology
    Washington D.C. DC. 20007
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Vanderbilt University Medical Center
    Nashville TN. 37208
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Thomas Jefferson University Hospital
    Philadelphia PA. 19107
    View Details

  • Platform Clinical Study for Conquering Scleroderma

    Oregon Health & Science University (OHSU)
    Portland OR. 97239
    View Details